Regenxbio Inc (NASDAQ:RGNX)
| 17.10 Delayed Data As of Sep 22 |  -0.52 / -2.95%Today’s Change | 16.93 Today|||52-Week Range 27.20 | -24.60% Year-to-Date |
Latest RGNX News | Press Releases
No recent news for Regenxbio Inc.
Today’s Trading
| Previous close | 17.62 |
| Today’s open | 17.31 |
| Day’s range | 17.10 - 17.51 |
| Volume | 13,542 |
| Average volume (3 months) | 366,529 |
| Market cap | $752.6M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -315.65% |
| Earnings growth (this year) | +31.55% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -76.03% |
| P/E ratio | NM |
| Price/Sales | 8.68 |
| Price/Book | 1.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IBRXImmunitybio Inc | +0.01 | +0.61% |
| SAVACassava Sciences Inc | -0.15 | -0.85% |
| ---- | ||
| ADMAADMA Biologics Inc | -0.04 | -1.12% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$1.10 |
| Annual revenue (last year) | $112.7M |
| Annual profit (last year) | -$280.3M |
| Net profit margin | -248.68% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
